Literature DB >> 12052834

Regulation of two JunD isoforms by Jun N-terminal kinases.

Oya Yazgan1, Curt M Pfarr.   

Abstract

The JunD transcription factor is one member of the Jun family of proteins that also includes c-Jun and JunB. Although c-Jun can function to promote cell proliferation and can cooperate with other oncogenes to transform cells, JunD slows proliferation of fibroblasts and antagonizes transformation by activated ras. Two isoforms of JunD, a full-length isoform containing 341 amino acids (JunD-FL) and a truncated isoform lacking 48 amino acids at the N terminus (Delta JunD), are generated through utilization of two translation start sites within a single mRNA. Here we show that both isoforms of JunD are phosphorylated by Jun N-terminal kinases (JNKs) at three identical residues and that both contain a docking domain that specifically binds JNKs. The JunD-FL isoform binds to and is phosphorylated by JNK more efficiently than Delta JunD in vitro; correspondingly, JunD-FL is a more potent transcriptional activator than Delta JunD. Although increased JNK signaling can activate both JunD isoforms, mutating either the JNK docking domain or the target JNK phosphorylation sites blocks this activation. These results identify two distinct isoforms of JunD with differential responses to JNK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052834     DOI: 10.1074/jbc.M204552200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  Inferring genetic interactions via a nonlinear model and an optimization algorithm.

Authors:  Chung-Ming Chen; Chih Lee; Cheng-Long Chuang; Chia-Chang Wang; Grace S Shieh
Journal:  BMC Syst Biol       Date:  2010-02-26

3.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 4.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

Review 5.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.

Authors:  Sigal Katz; Ami Aronheim
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  JunD and HIF-1alpha mediate transcriptional activation of angiotensinogen by TGF-beta1 in human lung fibroblasts.

Authors:  Amal Abdul-Hafez; Ruijie Shu; Bruce D Uhal
Journal:  FASEB J       Date:  2009-02-11       Impact factor: 5.191

8.  Computational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factors.

Authors:  Thomas C Whisenant; David T Ho; Ryan W Benz; Jeffrey S Rogers; Robyn M Kaake; Elizabeth A Gordon; Lan Huang; Pierre Baldi; Lee Bardwell
Journal:  PLoS Comput Biol       Date:  2010-08-26       Impact factor: 4.475

9.  TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.

Authors:  Cachétne S X Barrett; Ana C Millena; Shafiq A Khan
Journal:  Prostate       Date:  2016-09-07       Impact factor: 4.104

10.  Dissection of a complex transcriptional response using genome-wide transcriptional modelling.

Authors:  Martino Barenco; Daniel Brewer; Efterpi Papouli; Daniela Tomescu; Robin Callard; Jaroslav Stark; Michael Hubank
Journal:  Mol Syst Biol       Date:  2009-11-17       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.